David Perdue bought Emerson Electric Company (NYSE: EMR)
David Perdue bought EMR · disclosed August 28, 2017
David Perdue, a GA Senate member representing District N/A, purchased $15,001 - $50,000 of Emerson Electric Company (EMR) on August 9, 2017. Filings associated with David Perdue disclosed 0 other EMR transactions in the 12 months before this trade. Shares of EMR have risen 211.2% since the first observed purchase on August 9, 2017. The filing was publicly disclosed on August 28, 2017; a direct filing link is not available in the current data record.
Follow this and other congressional disclosures on the Quantellect congress trading dashboard. For David Perdue's complete filing history, visit David Perdue's full trade history. Browse all trading members of Congress tracked by Quantellect.
Key points
- Analyst ratings on EMR break down as 0 strong buy, 9 buy, 7 neutral, 1 sell, 0 strong sell.
- EMR carries a Risk Score of 94 as of November 20, 2026. On this scale, a higher score means a lower risk surface.
- David Perdue bought EMR in the amount range of $15,001 - $50,000 on August 9, 2017, filed under the STOCK Act.
- The filing lists Joint as the transaction owner and was disclosed 19 days after the trade.
- The asset description in the filing reads 'Emerson Electric Co..'
- Filings associated with David Perdue disclosed 0 other EMR transactions in the 12 months before this trade.
- Shares of EMR have risen 211.2% since the first observed purchase on August 9, 2017.
- EMR carried a Q Score of 0 in its equity peer group as of date unavailable.
- EMR carried a Squeeze Score of 20 as of November 22, 2026.
Did David Perdue buy or sell EMR?
The Periodic Transaction Report covers a single purchase involving EMR on August 9, 2017. The filed amount range is $15,001 - $50,000. The asset description reads 'Emerson Electric Co.', as submitted by the filer. The report was submitted on August 28, 2017. Under the STOCK Act, covered transactions generally must be reported within 30 days of receiving notice and no later than 45 days after the transaction.
| Politician | Action | Ticker | Amount | Trade date | Filed |
|---|---|---|---|---|---|
| David Perdue (Senate) | Buy | EMR | $15,001 - $50,000 | August 9, 2017 | August 28, 2017 |
What other EMR trades has David Perdue disclosed in the past 12 months?
Filings associated with David Perdue disclosed 0 other EMR transactions in the 12 months before this trade.
| Trade date | Action | Owner | Amount | Filing |
|---|---|---|---|---|
| No other EMR transactions were disclosed in the prior 12 months. | ||||
What does the filing show, and what does it not show?
The filing reports a purchase involving EMR by David Perdue in the amount range of $15,001 - $50,000, with Joint listed as the owner. It does not establish David Perdue's total holdings in EMR, any realized profit or loss, the reasons for the transaction, or any committee connection. The asset description reads 'Emerson Electric Co.', as submitted by the filer; that label is reproduced without adding a legal or regulatory interpretation. Quantellect's current profile data does not identify David Perdue's committee assignments, so this article draws no connection between the trade and any legislative jurisdiction. Filings associated with David Perdue disclosed 0 other EMR transactions in the 12 months before this trade. Quantellect tracks how disclosed purchases have performed, but does not treat corporate actions as buys or sells.
Who else in Congress traded EMR?
Quantellect's current database lists these recent EMR disclosures by other members. Owner labels come from the native filing row; an official filing link appears only when it is available in the source data.
| Member | Party | Action | Amount | Disclosed |
|---|---|---|---|---|
| Rohit Khanna Spouse | D House | Buy | $1,001 - $15,000 | October 7, 2026Filing unavailable |
| Kevin Hern Joint | R House | Sell | $15,001 - $50,000 | October 13, 2026Filing unavailable |
| Kevin Hern Joint | R House | Sell | $1,001 - $15,000 | September 25, 2026Filing unavailable |
| Kevin Hern Joint | R House | Sell | $15,001 - $50,000 | September 25, 2026Filing unavailable |
| Richard Dean Dr McCormick Self | R House | Sell | $1,001 - $15,000 | August 14, 2026Filing unavailable |
How has David Perdue's disclosed trading performed?
A current measured Member Score is not available for this member. Quantellect does not infer performance where the scored-trade projection lacks coverage.
All David Perdue EMR trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Frequently asked questions
Did David Perdue buy or sell EMR?
According to the disclosure, David Perdue purchased EMR on August 9, 2017.
What amount was reported for the EMR transaction?
The disclosure reports $15,001 - $50,000 for the purchase. Filed amounts are ranges, not exact transaction values.
When did the transaction occur, and when was it disclosed?
The transaction is dated August 9, 2017, and it was disclosed on August 28, 2017.
Where can I see David Perdue's other congressional trades?
Quantellect lists David Perdue's complete disclosed trade history on the member profile. David Perdue's trade history
Is congressional stock trading legal?
The STOCK Act does not impose a blanket ban on members holding or trading individual securities. It requires public disclosure of covered transactions, generally within 30 days of receiving notice and no later than 45 days after the transaction. Other laws and chamber rules may also apply. STOCK Act
Is Congress exempt from insider trading laws?
No. The STOCK Act expressly affirms that members and congressional employees are not exempt from federal insider-trading prohibitions and owe a duty arising from their positions. Public disclosure is a separate obligation and does not shield a trade from those laws. STOCK Act
How quickly must members of Congress disclose a trade?
Under the STOCK Act, a covered transaction generally must be reported on a Periodic Transaction Report within 30 days of receiving notice and no later than 45 days after the transaction. House Ethics guidance describes the reporting schedule and applicable late-filing fee. House Ethics PTR guidance
How is net worth reported in these disclosures?
It is not. STOCK Act filings report transaction and asset ranges, not a complete or real-time net worth. Quantellect does not estimate a member's net worth from these filings; any third-party estimate is not part of the official disclosure. STOCK Act
Browse all members of Congress who trade stocks·See which stocks Congress trades·Congressional trading overview
Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.

